The Department of Health and Aged Care have advised the Take Home Naloxone (THN) Program has been temporarily updated from 1 October 2023 to include an additional brand of naloxone: Nyxoid (UK) temporary S19A approval (naloxone 1.8 mg/actuation nasal spray, 2×1 actuation).
The PPA have updated the THN claim forms to include the new product. Approved Providers and Authorised Alternative Suppliers can begin lodging claims/data containing Nyxoid (UK) into the PPA Portal from 1 October 2023.
As both the Australian Nyxoid and the temporarily approved S19A Nyxoid (UK) are shown on the claim form, please ensure you are selecting the correct Nyxoid product when submitting data/claims into the PPA Portal.
Please Note: claims and data should not be submitted for Nyxoid (UK) supplied prior to 1 October 2023 (i.e. before the product was allowed to be supplied under the THN legislation). Claims submitted by an Approved Provider containing this naloxone product with a date of supply prior to 1 October 2023 will receive a payment of $0 for the Nyxoid (UK) component of the claim.
As per existing Program Rules, Authorised Alternative Suppliers do not receive payment for handing out naloxone products under the THN Program.